Boston Scientific BSX
NYSE BSX
$50.40 +1.03 (+2.10%)
As of: Aug 21, 2026 · 2:58 PM EDT

Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026)

Boston Scientific (BSX) posted quarterly Other Non-Current Liabilities of $2.5 billion for Q2 2026, up 4.07% year-over-year from $2.4 billion in Q2 2025, and little changed on a QoQ basis from $2.5 billion in Q1 2026.

Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Boston Scientific has reported Other Non-Current Liabilities for 18 years, with the latest figure at $2.5 billion in Q2 2026.

  • Other Non-Current Liabilities for Q2 2026 came in at $2.5 billion, up 4.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.5 billion (up 4.07% YoY), and the FY2025 annual result was $2.4 billion, up 28.61% from the prior year.
  • Other Non-Current Liabilities held at $2.5 billion in Q2 2026, from $2.5 billion in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $2.5 billion in Q2 2026 and troughed at $1.8 billion in Q2 2024.
  • A 5-year average of $2.1 billion and a median of $2.0 billion in 2022 frame the typical range for Other Non-Current Liabilities.
  • The widest annual swing landed in 2022, when Other Non-Current Liabilities slipped 16.55%; it then soared 32.39% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.0 billion in 2022, then declined by 3.34% to $2.0 billion in 2023, then decreased by 4.93% to $1.9 billion in 2024, then climbed by 28.61% to $2.4 billion in 2025, then gained by 3.12% to $2.5 billion in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.5 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.4 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.38 Bn 196.77 Bn 7.27 Bn
2 Stryker 126.28 Bn 122.80 Bn 4.50 Bn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn
4 Boston Scientific 74.10 Bn 73.56 Bn 3.85 Bn
5 Edwards Lifesciences 51.67 Bn 47.42 Bn 1.35 Bn
6 Dexcom 35.07 Bn 33.12 Bn 830.00 Mn
7 GE HealthCare Technologies 33.75 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.20 Bn 22.88 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.28 Bn 18.87 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.48 Bn
Mar 31, 2026 2.47 Bn
Dec 31, 2025 2.41 Bn
Sep 30, 2025 2.39 Bn
Jun 30, 2025 2.38 Bn
Mar 31, 2025 1.95 Bn
Dec 31, 2024 1.87 Bn
Sep 30, 2024 1.84 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.92 Bn
Dec 31, 2023 1.97 Bn
Sep 30, 2023 1.86 Bn
Jun 30, 2023 1.93 Bn
Mar 31, 2023 2.00 Bn
Dec 31, 2022 2.04 Bn
Sep 30, 2022 1.92 Bn
Jun 30, 2022 1.99 Bn
Mar 31, 2022 2.00 Bn
Dec 31, 2021 2.22 Bn
Sep 30, 2021 2.30 Bn